Researchers say a new drug for breast cancer will give patients vital extra time.
The drug called Kadcyla was trialled in Manchester and is now available to patients for the first time.
Doctors say it can extend women's lives by almost six months for those with the most aggressive form of the disease.
Around thirteen hundred women in England could benefit from the drug, which costs £6,000 a month.
Mel Barham reports
More top news
Construction work will begin on the successor submarines that carry the controversial Trident missiles, the Defence Secretary has said.
Ss Peter, Paul and St Philomena’s Church, New Brighton has received support from the Heritage Lottery Fund to restore two marble chapels
Ed Cooper, a student at Manchester Metropolitan University has been found dead at a halls of residence.